Table 2.
Response evaluation | Stage 1 | Stage 2 | ||
---|---|---|---|---|
Cycle 2 (N = 15) | Cycle 4 (N = 8) | Cycle 2 (N = 10) | Cycle 4 (N = 5) | |
WHO | ||||
Partial response | 1∗ | 0 | 0 | 0 |
Stable disease | 7 | 1 | 5 | 2 |
Progressive disease | 5 | 5 | 4 | 3 |
Others | 2 | 2 | 1 | 0 |
RECIST | ||||
Partial response | 0 | 0 | 0 | 0 |
Stable disease | 9 | 2 | 5 | 4 |
Progressive disease | 4 | 4 | 4 | 1 |
Others | 2 | 2 | 1 | 0 |
∗Partial response was unconfirmed and thus not counted as clinical benefit.